A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group

被引:3
|
作者
Crawford, E. David [1 ,15 ]
Garnick, Marc B. [2 ]
Eckel, Robert H. [3 ]
Miner, Martin M. [4 ]
Freedland, Stephen J. [5 ]
Pachynski, Russell K. [6 ]
Wassersug, Richard J. [7 ]
Rosenberg, Matthew T. [8 ]
Walker, Lauren M. [9 ]
Fairman, Ciaran [10 ]
Curley, Tracy [11 ]
Crosby, Michael [12 ]
Lin, Pao-Hwa [13 ]
Hafron, Jason M. [14 ]
机构
[1] Univ Calif San Diego, Dept Urol, La Jolla, CA USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Univ Colorado Denver, Anschutz Med Ctr, Div Endocrinol Metab & Diabet, Aurora, CO USA
[4] Brown Univ, Warren Alpert Sch Med, Providence, RI USA
[5] Cedars Sinai Med Ctr, Ctr Integrated Res Canc & Lifestyle, Los Angeles, CA USA
[6] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[7] Univ British Columbia, Vancouver, BC, Canada
[8] Midmichigan Hlth Ctr, Jackson, MI USA
[9] Univ Calgary, Dept Oncol, Dept Psychol, Calgary, AB, Canada
[10] Univ South Carolina, Dept Exercise, Columbia, SC USA
[11] Mem Sloan Kettering Canc Ctr, New York, NY USA
[12] Vet Prostate Canc Awareness Inc, San Diego, CA USA
[13] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[14] Michigan Inst Urol, West Bloomfield, MI USA
[15] Univ Calif San Diego, Dept Urol, Koman Family Outpatient Pavilion, La Jolla, CA 92037 USA
关键词
prostatic neoplasms; hormonal therapy; adverse effects; quality of life; lifestyle risk reduction; QUALITY-OF-LIFE; STYLE DIETARY PATTERN; CARDIOVASCULAR-DISEASE; RISK; MODALITIES; FRACTURE; FATIGUE; PATIENT;
D O I
10.1097/UPJ.0000000000000473
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction:To promote comprehensive care of patients throughout the androgen deprivation therapy (ADT) prescribing process, the Prostate Cancer 360 (PC360) Working Group developed monitoring and management recommendations intended to mitigate or prevent ADT-associated adverse events.Methods:The PC360 Working Group included 14 interdisciplinary experts with a dedicated clinical interest in prostate cancer and ADT management. The working group defined challenges associated with ADT adverse event management and then collaboratively developed comprehensive care recommendations intended to be practical for ADT prescribers.Results:The PC360 Working Group developed both overarching recommendations for ADT adverse event management and specific recommendations across 5 domains (cardiometabolic, bone, sexual, psychological, and lifestyle). The working group recommends an interdisciplinary, team-based approach wherein the ADT prescriber retains an oversight role for ADT management while empowering patients and their primary and specialty care providers to manage risk factors. The PC360 recommendations also emphasize the importance of proactive patient education that involves partners or other support providers. Recommended monitoring and assessment tools, risk factor management, and patient counseling points are also included for the 5 identified domains, with an emphasis on lifestyle and behavioral interventions that can improve quality of life and reduce the risk for ADT-associated complications.Conclusions:Comprehensive care of patients receiving ADT requires early and ongoing coordinated management of a variety of health domains, including cardiometabolic, bone, sexual, psychological health. Patient education and primary care provider involvement should begin prior to ADT initiation and continue throughout treatment to improve patient and partner quality of life.
引用
收藏
页码:18 / 29
页数:14
相关论文
共 50 条
  • [1] Development of a Multidisciplinary Care Pathway for Fracture Prevention in Men with Prostate Cancer at Initiation of Androgen Deprivation Therapy
    van Oostwaard, Marsha M.
    van den Bergh, Joop P.
    van de Wouw, Agnes J.
    de Jong, Marc
    Janssen-Heijnen, Maryska L.
    Wyers, Caroline E.
    CANCERS, 2024, 16 (15)
  • [2] Falls in men on androgen deprivation therapy for prostate cancer
    Hussain, Shabbir
    Breunis, Henriette
    Timilshina, Narhari
    Alibhai, Shabbir M. H.
    JOURNAL OF GERIATRIC ONCOLOGY, 2010, 1 (01) : 32 - 39
  • [3] Primary Androgen Deprivation Therapy in Men With Prostate Cancer
    Laufman, Leslie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (01): : 35 - 35
  • [4] Complications of Androgen Deprivation Therapy in Men With Prostate Cancer
    Patil, Tejas
    Bernard, Brandon
    ONCOLOGY-NEW YORK, 2018, 32 (09): : 470 - 475
  • [5] Complications of androgen deprivation therapy in men with prostate cancer
    Chen A.C.
    Petrylak D.P.
    Current Oncology Reports, 2004, 6 (3) : 209 - 215
  • [6] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [7] Fracture risk in men with prostate cancer on androgen deprivation therapy
    Krupski, TL
    Smith, MR
    Lee, WC
    Pashos, CL
    Brandman, J
    Wang, Q
    Botteman, MF
    Litwin, MS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 116 - 116
  • [8] Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer
    Young, James W. S.
    Sutradhar, Rinku
    Rangrej, Jagadish
    Marras, Connie
    Fleshner, Neil
    Alibhai, Shabbir M. H.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (09) : 1417 - 1423
  • [9] Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer
    James W. S. Young
    Rinku Sutradhar
    Jagadish Rangrej
    Connie Marras
    Neil Fleshner
    Shabbir M. H. Alibhai
    World Journal of Urology, 2017, 35 : 1417 - 1423
  • [10] Physical function in men with prostate cancer on androgen deprivation therapy
    Clay, Cheryl A.
    Perera, Subashan
    Wagner, Julie M.
    Miller, Megan E.
    Nelson, Joel B.
    Greenspan, Susan L.
    PHYSICAL THERAPY, 2007, 87 (10): : 1325 - 1333